Markets › United States › NYSE › ZBH

Zimmer Biomet Holdings Inc

NYSE:ZBHHealthcareCBOE:SPESGSTOXX:EDD24BP

$94.99+0.01%At closeAt close · Tue 20 Oct · ≈ AED 348.85 · Market cap $18.12B · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	70.2%	71.3%	70.9%	71.8%	71.5%	61.6%	—	—
Operating margin	1.4%	12.6%	10.0%	17.3%	16.7%	16.5%	16.5%	+0.0 pts
Net margin	−2.3%	5.9%	3.3%	13.8%	11.8%	8.6%	8.6%	+0.0 pts
EBITDA margin	16.4%	24.1%	21.5%	30.0%	29.3%	26.9%	—	—
Return on equity	−1.1%	3.2%	1.9%	8.2%	7.2%	5.6%	5.6%	−0.0 pts
Return on assets	−0.6%	1.7%	1.1%	4.8%	4.2%	3.1%	3.1%	+0.0 pts
Return on capital employed	0.4%	4.3%	3.7%	6.9%	6.8%	6.6%	—	—
Debt / equity	0.7×	0.6×	0.5×	0.5×	0.5×	0.6×	0.6×	−0.1%
Debt / assets	33.3%	30.1%	27.0%	26.8%	29.0%	32.6%	—	—
Interest coverage	0.4×	4.1×	4.2×	6.4×	5.9×	4.7×	—	—
Current ratio	2.0×	1.4×	1.9×	1.6×	1.9×	2.0×	2.0×	+0.0%
Quick ratio	1.0×	0.8×	1.0×	0.8×	1.0×	1.1×	—	—
Cash ratio	0.3×	0.1×	0.2×	0.1×	0.2×	0.2×	0.2×	+0.0%
Asset turnover	0.3×	0.3×	0.3×	0.3×	0.4×	0.4×	—	—
Inventory turnover	0.7×	0.9×	0.9×	0.9×	1.0×	1.4×	—	—
Receivables turnover	4.2×	5.4×	5.0×	5.1×	5.2×	4.8×	—	—
Dividend payout	−142.9%	49.8%	86.9%	19.6%	21.7%	27.0%	—	—